Use of insurance claims data to assess outpatient antimicrobial therapy for gram-positive infections

Pharmacotherapy

Volumn 22, Issue 2 II, 2002, Pages

  Carmeli, Yehuda ^a   Mozaffari, Essy ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; FEMALE; GRAM NEGATIVE INFECTION; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; PRESCRIPTION; REIMBURSEMENT; RISK ASSESSMENT;

EID: 0036151698     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.4.55s.33652     Document Type: Article

References (17)

1. Economic, clinical, and psychosocial outcomes of home infusion therapy: A review of published studies
2. Economics of home intravenous services
3. Cost-effectiveness of outpatient parenteral antibiotics: A review of the literature
4. Intravenous antibiotic therapy in an outpatient setting
5. Savings from outpatient antibiotic therapy for osteomyelitis: Economic analysis of a therapeutic strategy
6. Financial impact of a home intravenous antibiotic program on a Medicare managed care program
7. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program
8. Treating bone and joint infections with teicoplanin: Hospitalization vs outpatient cost issues
9. Outpatient use of ceftriaxone: A cost-benefit analysis
10. Linezolid: A review of its use in the management of serious gram-positive infections
11. Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: A randomized, multicenter trial
12. A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use
13. Targeted review of vancomycin use
14. Drug utilization review in a teaching hospital: Experience with vancomycin
15. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium
16. Vancomycin use in a university medical center: Effect of a vancomycin continuation form
17. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus